Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

NCT00071084

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Stanford University Med Ctr., Dept of Dermatology Stanford, California, United States
  • University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
  • Münster, Germany
  • Stockholm, Sweden
View Trial Details
Completed

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

NCT00585195

Conditions
Advanced Malignancies Except Leukemia, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of California, Irvine Medical Center Orange, California, United States
  • University of Colorado Hospital/ Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • University of Colorado Aurora, Colorado, United States
View all 29 locations
View Trial Details
Completed

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

NCT01607892

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +35 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions